Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis

被引:108
作者
Caminati, Antonella [1 ]
Bianchi, Achille [1 ]
Cassandro, Roberto [1 ]
Mirenda, Maria Rosa [1 ]
Harari, Sergio [1 ]
机构
[1] Osped San Giuseppe Fatebenefratelli, Serv Fisiopatol Resp Emodinam Polmonare, Unita Operat Pneumol & Terapia Semiintens Resp, I-20123 Milan, Italy
关键词
6-MWT; Pulmonary fibrosis; Prognostic factor; Interstitial lung diseases; 6-MINUTE WALK; INTERSTITIAL PNEUMONIA; PREDICTING SURVIVAL; HISTOLOGIC PATTERN; NORMAL VALUES; LUNG; TESTS; EXERCISE; HYPERTENSION; FEATURES;
D O I
10.1016/j.rmed.2008.07.022
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim of the work: Idiopathic pulmonary fibrosis (IPF) is a progressive disease with high mortality rates and a median survival of 2-3 years from time of diagnosis. The prognosis for any individual patient, however, is variable. To elucidate the clinical significance of 6-min walking test (6-MWT) in patients with IPF, we sought to assess the relationship between distance walked and desaturation during this test and pulmonary function tests (PFTs). We also evaluate the prognostic value of 6-MWT in comparison with PFTs at baseline and during follow-up. Methods: The clinical data of 44 patients with IPF were retrospectively analysed. Twenty-nine patients had an additional evaluation after 12 month of follow-up. Results: Distance walked in 6 min was independently related to mortality by multivariate analysis. Patients walking Less then 212 m had a significantly lower survival than those walking farther, assessed by Kaplan-Meier survival curves (log-rank test, p < 0.036). During a mean follow-up period of 19.8 months (range 3.2-46.4), 11 patients died of causes related to disease. Changes in meters walked at 12 months evaluation were also predictive of survival (p = 0.05). Conclusions: These results confirm that in IPF distance walked in 6 min is independent associated with mortality. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:117 / 123
页数:7
相关论文
共 47 条
[1]  
AGUSTI AG, 1988, EUR RESPIR J, V1, P510
[2]   MECHANISMS OF GAS-EXCHANGE IMPAIRMENT IN IDIOPATHIC PULMONARY FIBROSIS [J].
AGUSTI, AGN ;
ROCA, J ;
GEA, J ;
WAGNER, PD ;
XAUBET, A ;
RODRIGUEZROISIN, R .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 143 (02) :219-225
[3]  
*AM ASS RESP CAR, 2001, RESP CARE, V46, P514
[5]  
[Anonymous], 1995, AM J RESP CRIT CARE, V152, P2185
[6]  
[Anonymous], 2000, AM J RESP CRIT CARE, V161, P646, DOI [10.1164/ajrccm.161.2.ats3-00, DOI 10.1164/AJRCCM.161.2.ATS3-00]
[7]   Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis [J].
Bjoraker, JA ;
Ryu, JH ;
Edwin, MK ;
Myers, JL ;
Tazelaar, HD ;
Schroeder, DR ;
Offord, KP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (01) :199-203
[8]   2-MINUTE, 6-MINUTE, AND 12-MINUTE WALKING TESTS IN RESPIRATORY-DISEASE [J].
BUTLAND, RJA ;
PANG, J ;
GROSS, ER ;
WOODCOCK, AA ;
GEDDES, DM .
BRITISH MEDICAL JOURNAL, 1982, 284 (6329) :1607-1608
[9]   The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure [J].
Cahalin, LP ;
Mathier, MA ;
Semigran, MJ ;
Dec, GW ;
DiSalvo, TG .
CHEST, 1996, 110 (02) :325-332
[10]  
Caminati A, 2005, SARCOIDOSIS VASC DIF, V22, pS24